Lavinia Martino

Medicine & Life Sciences

1. Sildenafil Citrate 100%
2. Pulmonary Hypertension 79%
3. Bronchiolitis Obliterans 73%
4. Chronic Obstructive Pulmonary Disease 70%
5. Lung Compliance 69%
6. Multicenter Studies 69%
7. Pulmonary Arterial Hypertension 62%
8. Randomized Controlled Trials 53%
9. Epigenomics 46%
10. Cardiac Catheterization 45%
11. Placebos 44%
12. Lung 36%
13. Vascular Resistance 34%
14. Hemodynamics 33%
15. Partial Pressure 25%
16. Pulmonary Gas Exchange 19%
17. Quality of Life 18%
18. Phosphodiesterase 5 Inhibitors 18%
19. Histone Methyltransferases 18%
20. Transplants 17%
21. Walk Test 17%
22. Oxygen 15%
23. Histone Deacetylases 15%
24. Lung Transplantation 15%
25. Myofibroblasts 15%
26. Histone Code 15%
27. Untranslated RNA 14%
28. Therapeutics 14%
29. Dyspnea 12%
30. Mesenchymal Stem Cells 11%
31. MicroRNAs 11%
32. Body Mass Index 10%
33. Systemic Scleroderma 10%
34. Lung Volume Measurements 9%
35. Exercise 9%
36. Confidence Intervals 8%
37. Safety 8%
38. Carbon Monoxide 7%
39. ROC Curve 7%
40. Area Under Curve 7%
41. Sensitivity and Specificity 6%
42. Gases 6%
43. Multivariate Analysis 6%
44. In Vitro Techniques 5%
45. Population 5%
46. Pharmaceutical Preparations 5%